![Harold David Gunn](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Oorsprong van het eerstegraads netwerk van Harold David Gunn
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Qu Biologics, Inc.
![]() Qu Biologics, Inc. BiotechnologyHealth Technology Qu Biologics, Inc. develops site specific immunomodulators that aim to restore the body's innate immune system to treat cancer. The firm specializes in ulcerative colitis, Crohn's disease, arthritis, cancer, autoimmune diseases, autoimmune disorders, inflammatory bowel disease, IBD, Site Specific Immunomodulators, immunotherapies, investigational drug, auto-immune, pharmaceuticals, research, inflammation, biotech and clinical trials. The company was founded by Harold David Gunn and Rob Freeman in 2007 and is headquartered in Burnaby, Canada.
10
| Holding Company | Biotechnology | 10 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Harold David Gunn via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
University of British Columbia | College/University | Corporate Officer/Principal Graduate Degree Undergraduate Degree Doctorate Degree | |
University of Toronto | College/University | Corporate Officer/Principal Graduate Degree | |
University of Cambridge | College/University | Doctorate Degree | |
ME THERAPEUTICS HOLDINGS INC. | Biotechnology | Chief Executive Officer | |
Ontario Cancer Institute | Chief Executive Officer | ||
Princess Margaret Hospital | President | ||
British Columbia Cancer Foundation | President | ||
Canadian Partnership Against Cancer Corp.
![]() Canadian Partnership Against Cancer Corp. Miscellaneous Commercial ServicesCommercial Services Canadian Partnership Against Cancer initiates and implements cancer control programs. It offers prevention and screening; diagnosis and clinical care; person-centered perspective; research; system performance; knowledge management; and public engagement and outreach. The company is headquartered in Toronto, Canada. | Miscellaneous Commercial Services | Chairman | |
PREMIER DIVERSIFIED HOLDINGS INC. | Investment Managers | Chairman | |
Institute for Health System Transformation & Sustainability
![]() Institute for Health System Transformation & Sustainability Medical/Nursing ServicesHealth Services Institute for Health System Transformation & Sustainability operates to improve health care systems in British Columbia. Its projects include NeuroDevNet, emergency medicine network, and ministry projects. The company was founded in 2010 and is headquartered in Vancouver, Canada. | Medical/Nursing Services | Chairman | |
International Cancer Control Congress Association | President | ||
International Network For Cancer Treatment & Research | Corporate Officer/Principal | ||
Michael Smith Foundation for Health Research
![]() Michael Smith Foundation for Health Research Investment Trusts/Mutual FundsMiscellaneous The Michael Smith Foundation for Health Research operates as a health research funding agency. The non-profit company is based in Vancouver, Canada. Diane Finegood has been the CEO of the Canadian company since 2012. | Investment Trusts/Mutual Funds | Chairman | |
BC Cancer Agency
![]() BC Cancer Agency Medical/Nursing ServicesHealth Services BC Cancer Agency provides healthcare services. The firm serves for hereditary cancer, indigenous cancer care, interpreters, and psychiatry. Its services include assessment and follow-up library, nutrition services, pain and symptom management, patient and family counselling, PET functional imaging, primary care, screening programs, and speech-language pathology. The company was founded on November 5, 1938 and is headquartered in Vancouver, Canada. | Medical/Nursing Services | Chief Executive Officer | |
Genome British Columbia
![]() Genome British Columbia Miscellaneous Commercial ServicesCommercial Services Genome British Columbia invests in and manages genomics and proteomics research projects. It offers services in human health, environment, agriculture, forestry, mining, energy, aquaculture, and fisheries. The company was founded in 2000 and is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | Director/Board Member | |
Premier Diagnostic Center (Vancouver), Inc.
![]() Premier Diagnostic Center (Vancouver), Inc. Medical/Nursing ServicesHealth Services Part of Premier Diversified Holdings, Inc., Premier Diagnostic Center (Vancouver), Inc. engages in providing, designing and operating advanced nuclear medicine diagnostic imaging services. The company is based in Vancouver, Canada. The CEO of the Canadian company is Simon Sutcliffe. | Medical/Nursing Services | Chief Executive Officer | |
Deep Genomics, Inc.
![]() Deep Genomics, Inc. BiotechnologyHealth Technology Deep Genomics, Inc. provides machine learning, genome biology and precision medicine. It develops an integrated computational system that could learn, predict, and interpret how genetic variation, whether natural or therapeutic, alters crucial cellular processes. The firm offers SPIDEX database, which is a set of genetic variants and their predicted effects on human splicing across the entire genome. Its SPIDEX database covers all synonymous, missense, and nonsense exonic SNVs, as well as intronic SNVs that are up to 300nt from splice junctions. The company was founded by Brendan Frey and Hui Yuan Xiong in 2015 and is headquartered in Toronto, Canada. | Biotechnology | Chief Operating Officer | |
St Bartholomew's Hospital Medical College | College/University | Doctorate Degree | |
Omnitura Therapeutics, Inc.
![]() Omnitura Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Omnitura Therapeutics, Inc. is a biopharmaceutical company engaged in the commercialization of Multifunctional Multitargeted pharmaceuticals for oncology, a new class of therapies that is design to address the fundamentally complex and heterogeneous nature of cancer. The firm's product Aneustat, is a non-toxic, orally delivered, multivalent I-O drug candidate design to intercept, treat, and prevent cancer. The company was founded by James Dao and Jeffrey Dao in 2001 and is headquartered in Burlingame, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Initio Medical Group, Inc. | Chief Executive Officer | ||
Cci Cancer Control, Inc. | Corporate Officer/Principal | ||
Bold Therapeutics, Inc.
![]() Bold Therapeutics, Inc. BiotechnologyHealth Technology Bold Therapeutics, Inc. is a Canadian clinical-stage biopharmaceutical company that was founded in 2018 by a team of industry veterans to develop and commercialize novel therapeutics. The company is based in Vancouver, Canada. The company's focus is on developing Bold-100, a drug that has the potential to significantly improve outcomes in a wide range of both solid and liquid tumors in combination with other anticancer therapies. Edward Russell McAllister has been the CEO of the company since 2018. | Biotechnology | Director/Board Member | |
Terramera, Inc.
![]() Terramera, Inc. Chemicals: AgriculturalProcess Industries Terramera, Inc. manufactures pesticides and agrochemicals products. It offers biopesticides for the control of bed bugs and other household pests, biopesticides for agricultural use in a variety of crops and applications for bee health, cold pressed neem oil, neem cake, karanja oil, karanja cake, and other ecologically friendly products for use in agriculture, human health, and cosmetic applications; and other professional products. The company was founded by Karn Manhas and is headquartered in Vancouver, Canada. | Chemicals: Agricultural | Founder | |
McGill University | College/University | Undergraduate Degree | |
Young Presidents' Organization, Inc.
![]() Young Presidents' Organization, Inc. Miscellaneous Commercial ServicesCommercial Services Young Presidents' Organization, Inc. is a global leadership community of over 30,000 chief executives from 142 countries. The non-profit company is based in Irving, TX and has a global presence of subsidiaries in several regions. The company's mission is to help its members become better leaders and better people. The company was founded in 1950 by Ray Hickok, Khalid Mohamed Jassem Kanoo. Thayer Smith has been the CEO of the company since 2007. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
AURINIA PHARMACEUTICALS INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Vifor Pharma Management AG
![]() Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Vifor Pharma Management AG develops and manufactures pharmaceuticals products for the treatment of iron deficiency. It also offers a diversified portfolio of prescription medicines as well as over-the-counter products. The company operates in the following key business areas: iron deficiency with and without anemia, kidney disease, infectious diseases/OTX products and consumer healthcare, with a focus on non-prescription products. Vifor Pharma Management was founded by Caspar Friedrich Hausmann in 1872 and is headquartered in Glattbrugg, Switzerland. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
KANE BIOTECH INC. | Miscellaneous Commercial Services | Director/Board Member | |
DIANTHUS THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
IDENIX PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member | |
ImStar Therapeutics, Inc.
![]() ImStar Therapeutics, Inc. BiotechnologyHealth Technology ImStar Therapeutics, Inc. develops therapies for ALS and neurodegenerative disease. The firm's lead drug candidate is IMS-088, a small-molecule compound currently in preclinical development. It is studying compounds directed at a proprietary new therapeutic target for ALS called TANA. The company was founded by Daniel J. Wattier and Jean-Pierre Julien in 2012 and is headquartered in Vancouver, Canada. | Biotechnology | Chairman | |
Phoenix Molecular Designs Ltd.
![]() Phoenix Molecular Designs Ltd. Miscellaneous Commercial ServicesCommercial Services Phoenix Molecular Designs operates as a biopharmaceutical company. It focuses on developing first-in-class inhibitors against ribosomal S6 kinase (RSK), an important drug target for cancer, heart disease, and inflammation. The company was founded by Sandra Dunn in 2012 and is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | Director/Board Member | |
Novartis Corp.
![]() Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Executive Officer | |
University of Alberta | College/University | Graduate Degree | |
Novartis Pharma AG
![]() Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | General Counsel | |
Conoco Canada Ltd.
![]() Conoco Canada Ltd. Oil & Gas ProductionEnergy Minerals Part of ConocoPhillips, Conoco Canada Ltd. is the Canadian division of ConocoPhillips, the world's largest independent exploration and production company based on production and proved reserves. ConocoPhillips explores for, develops, and produces crude oil and natural gas in Canada. | Oil & Gas Production | General Counsel | |
DuPont Pharmaceuticals Co.
![]() DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | Pharmaceuticals: Major | General Counsel | |
MacKimmie Matthews | Corporate Officer/Principal | ||
ContextMedia Health LLC
![]() ContextMedia Health LLC Medical/Nursing ServicesHealth Services Contextmedia Health LLC owns and operates a digital healthcare networks. It provides condition-specific programming and ad-supported content at point-of-care facilities. The firm also empowers healthcare professionals to engage patients while curating content personalized for each member office. The company was founded by Shradha Agarwal and Rishi U. Shah in 2006 and is headquartered in Chicago, IL. | Medical/Nursing Services | Director/Board Member | |
Twinstrand Therapeutics, Inc.
![]() Twinstrand Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Twinstrand Therapeutics Inc. manufactures and distributes biological drugs. It focuses on discovering, developing and commercializing of therapeutics for the treatment of cancer, hepatitis A, cytomegalovirus, malaria, schistosomiasis, and fungal diseases. The company was founded in 1995 and is located in North Vancouver, Canada. | Pharmaceuticals: Major | Director/Board Member | |
University of London | College/University | Doctorate Degree | |
Novartis Pharmaceuticals Corp.
![]() Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | General Counsel | |
Canadian Federation of Biological Societies | President |
Statistieken
Internationaal
Canada | 36 |
Verenigde Staten | 10 |
Verenigd Koninkrijk | 4 |
Zwitserland | 3 |
België | 2 |
Sectoraal
Health Technology | 21 |
Consumer Services | 8 |
Commercial Services | 7 |
Health Services | 5 |
Finance | 2 |
Operationeel
Director/Board Member | 35 |
President | 9 |
Corporate Officer/Principal | 9 |
Chairman | 9 |
Chief Executive Officer | 7 |
Sterkste connecties
Insiders | |
---|---|
Julia G. Levy | 22 |
Simon Sutcliffe | 19 |
Robert E. Pelzer | 12 |
Rashieda Gluck | 7 |
Karn Manhas | 5 |
Matt Cahill | 4 |
Salim Dhanji | 4 |
Mike Leschuk | 1 |
Yuchen Xia | 1 |
Rob Freeman | 1 |
- Beurs
- Insiders
- Harold David Gunn
- Bedrijfsconnecties